We demonstrated that hyperglycemia-induced upregulation of endothelial ADAM17 contributed to numerous key responses linked to DR pathogenesis, including oxidative stress, inflammation, and vascular barrier breakdown. This evidence concerns the gene ADAM17 and Hyperglycemia.